SCHEMBL1650870

SCHEMBL1650870

CC(=O)c1cccc[n+]1CCO.O=S(=O)([O-])c1ccccc1

nearest known ligand 0.35

Known targets — ChEMBL curated mechanism

CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
KMT2A Q03164 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
MAPK1 P28482 1/20 0.33
CA12 O43570 1/20 0.33
CA9 Q16790 1/20 0.33
HSD11B1 P28845 2/20 0.33
BCAT1 P54687 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
PKM P14618 1/20 0.32
POLB P06746 2/20 0.32
PSIP1 O75475 1/20 0.32
HSP90AA1 P07900 1/20 0.32
PABPC1 P11940 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL146684 0.93 LMNA (0.38) CYP2D6ALDH1A1KMT2AKDM4ELMNA
Sulfuric Acid SCHEMBL1030156 0.90 CYP2D6 (0.34) CYP2D6CYP2C19ALDH1A1KDM4EPOLB
Sulfuric Acid SCHEMBL2185375 0.90 CYP2D6 (0.34) CYP2D6CYP2C19ALDH1A1KMT2AKDM4E
SCHEMBL149591 0.87 CYP2D6 (0.39) CYP2D6CYP2C19ALDH1A1KMT2AKDM4E
SCHEMBL290496 0.86 HSD11B1 (0.37) CYP2D6CYP2C19ALDH1A1GAAKMT2A
SCHEMBL291055 0.85 MAPK1 (0.38) CYP2D6CYP2C19ALDH1A1GAAKMT2A
Acetic Acid SCHEMBL1716571 0.85 CYP2D6 (0.36) CYP2D6CYP2C19GAAKMT2APOLB
Bromide SCHEMBL1652337 0.85 CYP2D6 (0.38) CYP2D6CYP2C19ALDH1A1KMT2AKDM4E
Hydrochloric Acid SCHEMBL1717299 0.85 CYP2D6 (0.38) CYP2D6CYP2C19ALDH1A1KMT2AKDM4E
SCHEMBL290641 0.84 CYP2D6 (0.35) CYP2D6CYP2C19ALDH1A1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2263642-B1 Colouring bleaches HENKEL AG & CO KGAA (DE) 2020-04-15 EP disclosed
US-8277516-B2 Lightening agent having cationic acylpyridinium derivatives and certain ammonium compounds HENKEL AG & CO. KGAA (DE) 2012-10-02 US disclosed
US-8277517-B2 Lightening agent having cationic acylpyridinium derivatives and certain amino acids HENKEL AG & CO. KGAA (DE) 2012-10-02 US disclosed
EP-2488154-A2 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMINO ACIDS Henkel AG & Co. KGaA (DE) 2012-08-22 EP disclosed
EP-2488155-A2 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS Henkel AG & Co. KGaA (DE) 2012-08-22 EP disclosed
US-20120192890-A1 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS HENKEL AG & CO. KGAA (DE) 2012-08-02 US disclosed
US-20120192891-A1 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMINO ACIDS HENKEL AG & CO. KGAA (DE) 2012-08-02 US disclosed
EP-2320854-B1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO KGAA (DE) 2012-01-18 EP disclosed
US-8034122-B2 Bleaching agent comprising 2-acylpyridinium derivatives HENKEL AG & CO. KGAA (DE) 2011-10-11 US disclosed
US-20110162671-A1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES HENKEL AG & CO. KGAA (DE) 2011-07-07 US disclosed
WO-2011045142-A2 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS HENKEL AG & CO. KGAA (DE) 2011-04-21 WO disclosed
WO-2011045134-A2 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMINO ACIDS HENKEL AG & CO. KGAA (DE) 2011-04-21 WO disclosed
EP-2263642-A2 Colouring bleaches Henkel AG & Co. KGaA (DE) 2010-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120192890-A1 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMMONIUM COMPOUNDS KRT18, AAAS, KATNAL2 CYP2D6 2612/4885CYP2C19 2920/4885ALDH1A1 127/4885
US-20110162671-A1 BLEACHING AGENT COMPRISING 2-ACYLPYRIDINIUM DERIVATIVES KRT18, CBR3, ACOX3 CYP2D6 758/4885CYP2C19 1434/4885ALDH1A1 401/4885
US-20120192891-A1 LIGHTENING AGENT HAVING CATIONIC ACYLPYRIDINIUM DERIVATIVES AND CERTAIN AMINO ACIDS ALAD, AADAT, ALDH7A1 CYP2D6 2480/4885CYP2C19 2444/4885ALDH1A1 140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.